PLA World Congress: Metabolix to Highlight Advances in PHA Biopolymer Technology

Metabolix, Inc., an advanced biomaterials company focused on sustainable solutions for the plastics and chemicals industries, today announced that it will highlight advances in its PHA (polyhydroxyalkanoate) biopolymer technology and its uses in modifying PLA (polylactic acid) at the 3rd PLA World Congress taking place May 27 and 28 in Munich, Germany.

Metabolix Vice President, Biopolymers, Bob Engle will present on PHA performance modifiers for PLA at the conference.

"There is a significant opportunity to expand the range of applications addressable by PLA, the current industry-leading biopolymer material, by rubber toughening it with PHA modifiers," Engle said. "We are developing proprietary PHA copolymer technology that is compatible with PLA and can modify PLA's properties to provide significant improvement in toughness and ductility, while still satisfying the market need for high bio-content and compostable solutions in applications such as single-use nonwovens, blister packaging and film."

Overview of Metabolix's PLA World Congress Presentation:

"PLA Modification Using New Mirel™ PHA Copolymers"
Tuesday, May 27 at 4:35 p.m. CEST

Metabolix has developed amorphous copolymers characterized with low glass transition temperatures to extend its PHA biopolymer performance capabilities. These PHA copolymers can effectively improve PLA's physical properties without compromising transparency, bio-content or compostability. Metabolix will showcase opportunities in a range of applications including fibers, sheet and film that are enabled by using Metabolix PHA modifier technology and highlight data on the PLA performance improvement. Metabolix is launching PLA masterbatch compounds incorporating the new Mirel PHA copolymers.

About Metabolix

Metabolix, Inc. is an advanced biomaterials company focused on sustainable solutions for the plastics and chemicals industries. The Company is developing and commercializing a family of high-performance biopolymers targeted at applications for performance additives that can improve performance and/or reduce cost in other material systems such as PVC, PLA and coated paper. Metabolix also is developing platforms for biobased chemicals based on its novel "FAST" recovery process and for co-producing plastics, chemicals and energy from crops. Metabolix has established an industry-leading intellectual property portfolio that, together with its knowledge of advanced industrial practice, provides a foundation for industry collaborations.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Yield10 Bioscience, Inc.. (2019, February 08). PLA World Congress: Metabolix to Highlight Advances in PHA Biopolymer Technology. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=41327.

  • MLA

    Yield10 Bioscience, Inc.. "PLA World Congress: Metabolix to Highlight Advances in PHA Biopolymer Technology". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=41327>.

  • Chicago

    Yield10 Bioscience, Inc.. "PLA World Congress: Metabolix to Highlight Advances in PHA Biopolymer Technology". AZoM. https://www.azom.com/news.aspx?newsID=41327. (accessed November 21, 2024).

  • Harvard

    Yield10 Bioscience, Inc.. 2019. PLA World Congress: Metabolix to Highlight Advances in PHA Biopolymer Technology. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=41327.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.